Erratum to: UDP-glucuronosyltransferase 1A16 and 28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer.

导出 OA

翻译打印收藏纠错

作者： Yoshinori,Miyata ^[1] ; Tetsuo,Touyama ^[2] ; Takaya,Kusumi ^[3] ; Yoshitaka,Morita ^[4] ; Nobuyuki,Mizunuma ^[5] ; Fumihiro,Taniguchi ^[6] ; Mitsuaki,Manabe ^[7]

作者单位： Department of Medical Oncology, Saku Central Hospital Advanced Care Center, 3400-28 Nakagomi, Saku, Nagano, 385‑0051, Japan. miyata.yoshinori@sakuhp.or.jp. ^[1] Department of Surgery, Nakagami Hospital, Okinawa, Japan. ^[2] Department of Surgery, Keiyukai Sapporo Hospital, Sapporo, Japan. ^[3] Department of Radiology, National Hospital Organization Kobe Medical Center, Kobe, Japan. ^[4] Department of Gastroenterology, Cancer Institute Hospital of Japanese Foundation for Cancer Research, Tokyo, Japan. ^[5] Hepato-Pancreatic Surgery Division, Japanese Red Cross Kyoto Daiichi Hospital, Kyoto, Japan. ^[6] Yakult Honsha Co., Ltd., Tokyo, Japan. ^[7]

DOI 10.1007/s10147-016-1006-9

PMID 27380166

发布时间 2019-11-20

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览7

International journal of clinical oncology

2016年21卷4期

704页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Erratum to: UDP-glucuronosyltransferase 1A16 and 28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer.

International journal of clinical oncology

相似文献

International journal of clinical oncology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Erratum to: UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer.

International journal of clinical oncology

相似文献

International journal of clinical oncology

相关期刊

检索历史清除

Erratum to: UDP-glucuronosyltransferase 1A16 and 28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer.